In a series of 270 CDH1 PV carriers with a follow up time of 31.1 months, 97% with a family history of gastric cancer, 58 patients were diagnosed with SRC in the absence of a macroscopic abnormality and continued 6 monthly endoscopic surveillance without progression to advanced DGC [16]. This evidence concerns the gene CDH1 and gastric cancer.